We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Divergent Effects in the Treatment of Hyperlipemia

Arch Intern Med. 1965;116(4):523-530. doi:10.1001/archinte.1965.03870040037009.
Text Size: A A A
Published online


THORP AND WARING demonstrated that clofibrate (Atromid S) lowered levels of serum and liver cholesterol in rats.1 Other studies suggested that a mixture of androsterone and clofibrate (Atromid) potentiated the lipid-lowering effect.2 The successful use of this mixture to decrease serum lipid concentration in patients with coronary sclerosis by Oliver in 19623 prompted the present study of the effects of clofibrate alone or with androsterone in patients with frank disorders of lipid metabolism. In the course of these investigations, published reports suggested that clofibrate alone was responsible for the lipid-lowering action of the mixture and that addition of androsterone produced no enhancement.4-8

Materials and Methods  The patients (Table 1) ranged in age from 10 to 72 years. They included four men, three women with hyperlipemia, a boy with idiopathic hyperlipemia, and a boy with glycogen-storage disease (glucose-6-phosphatase deficient). In five of seven families studied familial incidence of hyperlipemia was demonstrated.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.